Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

History

Camera Life Sciences has been proudly providing medical-grade products to healthcare and life sciences customers across the globe since 1978. We are deeply committed to researching and developing innovative solutions to meet the ever-evolving needs of our customers.

Mission

Our mission is to inspire healthcare teams to improve the lives of patients, by continuously advancing healthcare by developing innovative and accessible medical-grade products.

Vision

Our vision is to become a global leader for healthcare safety, providing trusted medical-grade products to help our customers deliver the best care to their patients.

Key Team

Dr. Robert P. Mahoney Ph.D. (Chief Scientific Officer)

Mr. Michael G. Campbell CPA (Exec. VP & CFO)

Ms. Janice Marie McCourt B.S., CLP, M.B.A., R.Ph. (Chief Bus. Officer)

Recognition and Awards

We have received numerous awards for our innovative medical-grade products, including the International Medical Device Innovation Award and the International Device Manufacturing Excellence Award.

References

https://in.investing.com/equities/otr-acquisition

https://finance.yahoo.com/quote/CMRA/profile?p=CMRA

https://www.crunchbase.com/organization/reform-biologics

https://comeralifesciences.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Leadership team

Mr. Jeffrey S. Hackman (Chairman, Pres & CEO)

Dr. David Soane Ph.D. (Co-Founder & Member of Scientific Advisory Board)

Dr. Neal I. Muni M.D., MSPH (Exec. VP & COO)

Products/ Services

Biotechnology, Health Diagnostics, Therapeutics

Number of Employees

0 - 50

Headquarters

Woburn, Massachusetts, United States

Established

2014

Company Registration

SEC CIK number: 0001907685

Revenue

500K - 2M

Traded as

NASDAQ:CMRA

Social Media

URL

https://comeralifesciences.com

Last updated: Tue Feb 25 2025

We value your privacy

Comera Life Sciences

Table of content

Summary